Aloperine (ALO), an herbal medicine, elevates miR-296-5p levels, leading to decreased CRC cell proliferation by modulating Bax and Bcl-2 expression, as well as reduced cell migration and invasion by regulating N-cadherin and E-cadherin expression. Here, CDH2 is linked to colorectal carcinoma.